期刊文献+

1%卢立康唑乳膏与1%特比萘芬乳膏治疗股癣的随机、对照、双盲研究 被引量:5

A randomized,double-blind,controlled study with luliconazle cream(1%)versus terbinafine cream(1%)in patients with tinea cruris
下载PDF
导出
摘要 目的观察和评价1%卢立康唑乳膏治疗股癣的疗效和安全性。方法采用随机、双盲的原则将60例真菌镜检阳性的患者分为两组,治疗组外用1%卢立康唑乳膏,每天1次;对照组外用1%特比萘芬乳膏,每天1次。用药疗程均为2周。在开始用药后第1、2、4、8周评价临床和真菌学疗效。结果 60例患者均进入疗效分析。用药1周时,治疗组及对照组临床有效率分别为40%和23.3%,真菌清除率为23.3%和20%,用药2周时,治疗组及对照组临床有效率分别为80%和70%,真菌清除率为70%和63.3%,停药后6周,治疗组及对照组临床有效率分别为83.3%和70%,真菌清除率为80%和66.7%。结论 1%卢立康唑乳膏外用治疗股癣能迅速改善症状,复发率低,是安全有效的外用药物。 Objective To observe and assessment of the efficacy and safety of luliconazole cream(1%)in patients with tinea cruris.Method Sixty patients positive for fungal elements on direct microscopy were equally and randomly divided into 2groups:experimental group applying luliconazole cream(1%)once daily for 2weeks,control group applying terbinafine cream(1%)once daily for2 weeks.Efficacy was assessed on week 1,2,4,8after initiation of treatment.Result 60 patients were eligible for the efficacy analysis.On week 1after initiation of treatment,the clinical effective rate in the experimental group and control group was 40% VS 23.3%,the fungal clearance rate was 23.3% VS 20%.On week 2after initiation of treatment,the clinical effective rate in the experimental group and control group was 80% VS 70%,the fungal clearance rate was 70% VS 63.3%.On week 6after the end of treatment,the clinical effective rate in the experimental group and control group was 83.3% VS 70%,the fungal clearance rate was 80% VS 66.7%.Conclusion Luliconazole cream(1%)have strong ability in relieving signs and symptoms of patients and low recurrence rate.Luliconazole cream(1%)is effective and well tolerated in the treatment of tinea cruris.
出处 《中国真菌学杂志》 CSCD 2017年第1期38-41,共4页 Chinese Journal of Mycology
基金 中国中西医结合学会皮肤性病专业委员会临床研究基金(CAIM-LLKZ-006)
关键词 卢立康唑 特比萘芬 股癣 疗效 随机对照双盲 luliconazle terbinafine tinea cruris efficacy randomized double-blind controlled
  • 相关文献

参考文献1

二级参考文献13

  • 1Ryder NS. Terbinafine: mode of action and properties of the squalene epoxidase inhibition [J]. Br J Dennatol, 1992, 126 Suppl 39: 2-7.
  • 2Sud IJ, Feingold DS. Mechanisms of action of the antimycotic imidazoles[J]. J Invest Dennatol, 1981,76(6): 438-441.
  • 3Saito R, Sawada M, Ishizaki S, et al. A case of inflammatory tinea corporis by Epidennophyton l1occosum [J]. Nihon Ishinkin Gakkai Zasshi, 2008, 49(3): 211-215.
  • 4Katoh T. Guidelines for diagnosis and treatment of mucocutaneous candidiasis [J]. Nihon Ishinkin Gakkai Zasshi, 2009, 50 (4): 207-212.
  • 5Uchida K, Nishiyama Y, Tanaka T, et al. In vitro activity of novel imidazole antifungal agent NND-502 against MaIassezia species [J]. Int J Antimicrob Agents, 2003, 21( 3): 234-238.
  • 6Padhye AA, Weitzman I. The dennatophytesllAjello L, Hay RJ. Topley & Wilson's microbiology and microbial infections, volume 4: medical mycology [M]. 9th ed. London: Arnold, 1998: 215- 236.
  • 7Koga H, Nanjoh Y, Kaneda H, et al. Short-term therapy with luliconazole, a novel topical antifungal imidazole, in guinea pig models of tinea corporis and tinea pedis [J]. Antimicrob Agents Chemother, 2012, 56(6): 3138-3143.
  • 8Ghannoum MA, Long L, Kim HG, et al. Efficacy of terbinafine compared to lanoconazole and luliconazole in the topical treatment of dermatophytosis in a guinea pig model [J]. Med Mycol, 2010, 48(3): 491-497.
  • 9Watanabe S, Takabashi H, Nishikawa T, et al. Dose-finding comparative study of 2 weeks of luliconazole cream treatment for tinea pedis-comparison between three groups (1 %, 0.5%, 0.1 %) by a multi-center randomized double-blind study [J]. Mycoses, 2007,50(1): 35-40.
  • 10Watanabe S, Takabashi H, Nishikawa T, et aI. A comparative clinical study between 2 weeks of luliconazole 1 % cream treatment and 2 weeks of bifonazole 1 % cream treatment for tinea pedis[J]. Mycoses, 2006, 49(3): 236-241.

共引文献15

同被引文献41

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部